29Jul
National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer
On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By:
Manatt, Phelps & Phillips, LLP
Related
In the three-year old saga regarding anticipated changes to the minimum salary threshold for overtim...
Read More >
The 2019 Novel Coronavirus (“2019-nCoV” or “Coronavirus”) is a rapidly spreading respiratory ill...
Read More >
Keeping an eye on changes and trends in employment law is an excellent way for businesses to mitigat...
Read More >
Seyfarth Synopsis: Halloween was last week, and you probably thought all the scary ghouls and goblin...
Read More >
The trend toward limiting U.S. federal income tax benefits associated with public company executive ...
Read More >
The attractiveness of the United Kingdom as a business location is unabated. There are many advantag...
Read More >